Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · Real-Time Price · USD

74.55

+0.04 (0.05%)

At close: Oct 19, 2026, 4:00 PM EDT

74.55

0.00 (0.00%)

After-hours: Oct 19, 2026, 4:00 PM EDT

Utah Medical Products Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	237	179	208	306	365	365
Market Cap Growth	22.41%	-14.01%	-31.80%	-16.18%	-0.11%	18.97%
Enterprise Value	150	95	120	218	296	301
Last Close Price	74.51	55.20	59.36	79.88	94.09	92.37

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	22.70	15.89	15.03	18.38	22.14	24.69
Forward PE	-	17.80	17.80	17.80	17.80	17.80
PS Ratio	6.60	4.65	5.10	6.09	6.98	7.44
PB Ratio	1.94	1.50	1.78	2.38	3.19	3.41
P/TBV Ratio	2.21	1.72	2.07	2.79	4.03	4.85
P/FCF Ratio	20.81	12.52	14.28	14.12	17.93	17.68
P/OCF Ratio	20.10	12.20	14.06	13.72	17.25	17.22
PEG Ratio	-	1.19	1.19	1.19	1.19	1.19

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.18	2.47	2.94	4.34	5.65	6.14
EV/EBITDA Ratio	10.50	6.06	6.49	9.43	11.02	11.51
EV/EBIT Ratio	12.60	7.47	7.65	12.98	14.93	15.95
EV/FCF Ratio	13.18	6.65	8.24	10.06	14.53	14.58

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.02	0.02	0.01	0.01	0.02
Debt / FCF Ratio	0.02	0.02	0.02	0.01	0.02	0.02
Net Debt / Equity Ratio	-0.72	-0.72	-0.70	-0.72	-0.65	-0.56
Net Debt / EBITDA Ratio	-6.08	-5.44	-4.46	-4.01	-2.79	-2.32
Net Debt / FCF Ratio	-7.63	-5.97	-5.66	-4.28	-3.67	-2.93
Asset Turnover	0.29	0.31	0.32	0.39	0.44	0.43
Inventory Turnover	1.76	1.97	1.82	2.19	2.61	2.83
Quick Ratio	44.01	34.36	23.18	20.44	13.52	17.65
Current Ratio	48.62	37.62	25.64	22.56	15.09	19.54
Return on Equity (ROE)	8.76%	9.54%	11.29%	13.72%	14.88%	14.09%
Return on Assets (ROA)	6.10%	6.51%	7.62%	8.09%	10.33%	10.38%
Return on Invested Capital (ROIC)	28.71%	29.78%	36.87%	36.91%	36.65%	29.85%
Return on Capital Employed (ROCE)	9.80%	10.60%	13.20%	12.80%	16.80%	16.90%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.40%	6.30%	6.65%	5.44%	4.52%	4.05%
FCF Yield	4.81%	7.99%	7.00%	7.08%	5.58%	5.66%
Dividend Yield	1.66%	2.18%	1.93%	1.41%	1.16%	0.86%
Payout Ratio	37.78%	35.29%	30.70%	25.74%	19.20%	77.53%
Buyback Yield / Dilution	4.75%	7.51%	3.68%	0.17%	0.46%	0.33%
Total Shareholder Return	6.40%	9.69%	5.61%	1.57%	1.62%	1.18%

SEC Filings: 10-K · 10-Q